Takeda Pharmaceutical Co ADR’s recent filing unveils that its President, Plasma-Derived Ther Giles Richard Platford acquired Company’s shares for reported $0.28 million on Aug 23 ’24. In the deal valued at $14.94 per share,19,073 shares were bought.
Morgan Stanley upgraded its Takeda Pharmaceutical Co ADR [TAK] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including BofA Securities’s analysts, who increased its forecast for the stock in mid March from “a Neutral” to “a Buy”. Cowen also remained covering TAK and has increased its forecast on July 19, 2022 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on October 07, 2021. It rated TAK as “an Equal-weight” which previously was an “an Overweight”.
Price Performance Review of TAK
On Monday, Takeda Pharmaceutical Co ADR [NYSE:TAK] saw its stock jump 1.50% to $14.93. Over the last five days, the stock has gained 7.56%. Takeda Pharmaceutical Co ADR shares have risen nearly 12.76% since the year began. Nevertheless, the stocks have risen 13.54% over the past one year. While a 52-week high of $15.37 was reached on 04/03/25, a 52-week low of $12.57 was recorded on 01/23/25. SMA at 50 days reached $14.54, while 200 days put it at $14.03.
Levels Of Support And Resistance For TAK Stock
The 24-hour chart illustrates a support level at 14.85, which if violated will result in even more drops to 14.76. On the upside, there is a resistance level at 14.98. A further resistance level may holdings at 15.03. The Relative Strength Index (RSI) on the 14-day chart is 56.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.23, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 24.86%. Stochastics %K at 66.85% indicates the stock is a holding.
How much short interest is there in Takeda Pharmaceutical Co ADR?
A steep rise in short interest was recorded in Takeda Pharmaceutical Co ADR stocks on 2025-03-31, growing by 0.72 million shares to a total of 5.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 4.31 million shares. There was a rise of 14.26%, which implies that there is a positive sentiment for the stock.
